Artificial Intelligence Drug R&D Market, Global Outlook and Forecast 2024-2031

Report ID: 1133810 | Published Date: Jan 2025 | No. of Page: 62 | Base Year: 2024 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Artificial Intelligence Drug R&D Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Artificial Intelligence Drug R&D Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Artificial Intelligence Drug R&D Overall Market Size
    2.1 Global Artificial Intelligence Drug R&D Market Size: 2021 VS 2028
    2.2 Global Artificial Intelligence Drug R&D Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Artificial Intelligence Drug R&D Players in Global Market
    3.2 Top Global Artificial Intelligence Drug R&D Companies Ranked by Revenue
    3.3 Global Artificial Intelligence Drug R&D Revenue by Companies
    3.4 Top 3 and Top 5 Artificial Intelligence Drug R&D Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Artificial Intelligence Drug R&D Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Artificial Intelligence Drug R&D Players in Global Market
        3.6.1 List of Global Tier 1 Artificial Intelligence Drug R&D Companies
        3.6.2 List of Global Tier 2 and Tier 3 Artificial Intelligence Drug R&D Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Artificial Intelligence Drug R&D Market Size Markets, 2021 & 2028
        4.1.2 AI Platfrom
        4.1.3 Analytics Service
    4.2 By Type - Global Artificial Intelligence Drug R&D Revenue & Forecasts
        4.2.1 By Type - Global Artificial Intelligence Drug R&D Revenue, 2017-2022
        4.2.2 By Type - Global Artificial Intelligence Drug R&D Revenue, 2023-2028
        4.2.3 By Type - Global Artificial Intelligence Drug R&D Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Artificial Intelligence Drug R&D Market Size, 2021 & 2028
        5.1.2 Drug Discovery
        5.1.3 Precision Medicine
    5.2 By Application - Global Artificial Intelligence Drug R&D Revenue & Forecasts
        5.2.1 By Application - Global Artificial Intelligence Drug R&D Revenue, 2017-2022
        5.2.2 By Application - Global Artificial Intelligence Drug R&D Revenue, 2023-2028
        5.2.3 By Application - Global Artificial Intelligence Drug R&D Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Artificial Intelligence Drug R&D Market Size, 2021 & 2028
    6.2 By Region - Global Artificial Intelligence Drug R&D Revenue & Forecasts
        6.2.1 By Region - Global Artificial Intelligence Drug R&D Revenue, 2017-2022
        6.2.2 By Region - Global Artificial Intelligence Drug R&D Revenue, 2023-2028
        6.2.3 By Region - Global Artificial Intelligence Drug R&D Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Artificial Intelligence Drug R&D Revenue, 2017-2028
        6.3.2 US Artificial Intelligence Drug R&D Market Size, 2017-2028
        6.3.3 Canada Artificial Intelligence Drug R&D Market Size, 2017-2028
        6.3.4 Mexico Artificial Intelligence Drug R&D Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Artificial Intelligence Drug R&D Revenue, 2017-2028
        6.4.2 Germany Artificial Intelligence Drug R&D Market Size, 2017-2028
        6.4.3 France Artificial Intelligence Drug R&D Market Size, 2017-2028
        6.4.4 U.K. Artificial Intelligence Drug R&D Market Size, 2017-2028
        6.4.5 Italy Artificial Intelligence Drug R&D Market Size, 2017-2028
        6.4.6 Russia Artificial Intelligence Drug R&D Market Size, 2017-2028
        6.4.7 Nordic Countries Artificial Intelligence Drug R&D Market Size, 2017-2028
        6.4.8 Benelux Artificial Intelligence Drug R&D Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Artificial Intelligence Drug R&D Revenue, 2017-2028
        6.5.2 China Artificial Intelligence Drug R&D Market Size, 2017-2028
        6.5.3 Japan Artificial Intelligence Drug R&D Market Size, 2017-2028
        6.5.4 South Korea Artificial Intelligence Drug R&D Market Size, 2017-2028
        6.5.5 Southeast Asia Artificial Intelligence Drug R&D Market Size, 2017-2028
        6.5.6 India Artificial Intelligence Drug R&D Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Artificial Intelligence Drug R&D Revenue, 2017-2028
        6.6.2 Brazil Artificial Intelligence Drug R&D Market Size, 2017-2028
        6.6.3 Argentina Artificial Intelligence Drug R&D Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Artificial Intelligence Drug R&D Revenue, 2017-2028
        6.7.2 Turkey Artificial Intelligence Drug R&D Market Size, 2017-2028
        6.7.3 Israel Artificial Intelligence Drug R&D Market Size, 2017-2028
        6.7.4 Saudi Arabia Artificial Intelligence Drug R&D Market Size, 2017-2028
        6.7.5 UAE Artificial Intelligence Drug R&D Market Size, 2017-2028
7 Players Profiles
    7.1 IBM Watson
        7.1.1 IBM Watson Corporate Summary
        7.1.2 IBM Watson Business Overview
        7.1.3 IBM Watson Artificial Intelligence Drug R&D Major Product Offerings
        7.1.4 IBM Watson Artificial Intelligence Drug R&D Revenue in Global Market (2017-2022)
        7.1.5 IBM Watson Key News
    7.2 BioXel
        7.2.1 BioXel Corporate Summary
        7.2.2 BioXel Business Overview
        7.2.3 BioXel Artificial Intelligence Drug R&D Major Product Offerings
        7.2.4 BioXel Artificial Intelligence Drug R&D Revenue in Global Market (2017-2022)
        7.2.5 BioXel Key News
    7.3 Insilico Medicine
        7.3.1 Insilico Medicine Corporate Summary
        7.3.2 Insilico Medicine Business Overview
        7.3.3 Insilico Medicine Artificial Intelligence Drug R&D Major Product Offerings
        7.3.4 Insilico Medicine Artificial Intelligence Drug R&D Revenue in Global Market (2017-2022)
        7.3.5 Insilico Medicine Key News
    7.4 Gatehouse Bio
        7.4.1 Gatehouse Bio Corporate Summary
        7.4.2 Gatehouse Bio Business Overview
        7.4.3 Gatehouse Bio Artificial Intelligence Drug R&D Major Product Offerings
        7.4.4 Gatehouse Bio Artificial Intelligence Drug R&D Revenue in Global Market (2017-2022)
        7.4.5 Gatehouse Bio Key News
    7.5 Google DeepMind
        7.5.1 Google DeepMind Corporate Summary
        7.5.2 Google DeepMind Business Overview
        7.5.3 Google DeepMind Artificial Intelligence Drug R&D Major Product Offerings
        7.5.4 Google DeepMind Artificial Intelligence Drug R&D Revenue in Global Market (2017-2022)
        7.5.5 Google DeepMind Key News
    7.6 Genpact Cora
        7.6.1 Genpact Cora Corporate Summary
        7.6.2 Genpact Cora Business Overview
        7.6.3 Genpact Cora Artificial Intelligence Drug R&D Major Product Offerings
        7.6.4 Genpact Cora Artificial Intelligence Drug R&D Revenue in Global Market (2017-2022)
        7.6.5 Genpact Cora Key News
    7.7 Cyclica Inc
        7.7.1 Cyclica Inc Corporate Summary
        7.7.2 Cyclica Inc Business Overview
        7.7.3 Cyclica Inc Artificial Intelligence Drug R&D Major Product Offerings
        7.7.4 Cyclica Inc Artificial Intelligence Drug R&D Revenue in Global Market (2017-2022)
        7.7.5 Cyclica Inc Key News
    7.8 QuantumBlack
        7.8.1 QuantumBlack Corporate Summary
        7.8.2 QuantumBlack Business Overview
        7.8.3 QuantumBlack Artificial Intelligence Drug R&D Major Product Offerings
        7.8.4 QuantumBlack Artificial Intelligence Drug R&D Revenue in Global Market (2017-2022)
        7.8.5 QuantumBlack Key News
    7.9 Nq Medical
        7.9.1 Nq Medical Corporate Summary
        7.9.2 Nq Medical Business Overview
        7.9.3 Nq Medical Artificial Intelligence Drug R&D Major Product Offerings
        7.9.4 Nq Medical Artificial Intelligence Drug R&D Revenue in Global Market (2017-2022)
        7.9.5 Nq Medical Key News
    7.10 Phenomic AI
        7.10.1 Phenomic AI Corporate Summary
        7.10.2 Phenomic AI Business Overview
        7.10.3 Phenomic AI Artificial Intelligence Drug R&D Major Product Offerings
        7.10.4 Phenomic AI Artificial Intelligence Drug R&D Revenue in Global Market (2017-2022)
        7.10.5 Phenomic AI Key News
    7.11 Palantir Technologies
        7.11.1 Palantir Technologies Corporate Summary
        7.11.2 Palantir Technologies Business Overview
        7.11.3 Palantir Technologies Artificial Intelligence Drug R&D Major Product Offerings
        7.11.4 Palantir Technologies Artificial Intelligence Drug R&D Revenue in Global Market (2017-2022)
        7.11.5 Palantir Technologies Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Artificial Intelligence Drug R&D Market Opportunities & Trends in Global Market
    Table 2. Artificial Intelligence Drug R&D Market Drivers in Global Market
    Table 3. Artificial Intelligence Drug R&D Market Restraints in Global Market
    Table 4. Key Players of Artificial Intelligence Drug R&D in Global Market
    Table 5. Top Artificial Intelligence Drug R&D Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Artificial Intelligence Drug R&D Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Artificial Intelligence Drug R&D Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Artificial Intelligence Drug R&D Product Type
    Table 9. List of Global Tier 1 Artificial Intelligence Drug R&D Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Artificial Intelligence Drug R&D Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Artificial Intelligence Drug R&D Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Artificial Intelligence Drug R&D Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Artificial Intelligence Drug R&D Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Artificial Intelligence Drug R&D Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Artificial Intelligence Drug R&D Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Artificial Intelligence Drug R&D Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2023-2028
    Table 30. IBM Watson Corporate Summary
    Table 31. IBM Watson Artificial Intelligence Drug R&D Product Offerings
    Table 32. IBM Watson Artificial Intelligence Drug R&D Revenue (US$, Mn), (2017-2022)
    Table 33. BioXel Corporate Summary
    Table 34. BioXel Artificial Intelligence Drug R&D Product Offerings
    Table 35. BioXel Artificial Intelligence Drug R&D Revenue (US$, Mn), (2017-2022)
    Table 36. Insilico Medicine Corporate Summary
    Table 37. Insilico Medicine Artificial Intelligence Drug R&D Product Offerings
    Table 38. Insilico Medicine Artificial Intelligence Drug R&D Revenue (US$, Mn), (2017-2022)
    Table 39. Gatehouse Bio Corporate Summary
    Table 40. Gatehouse Bio Artificial Intelligence Drug R&D Product Offerings
    Table 41. Gatehouse Bio Artificial Intelligence Drug R&D Revenue (US$, Mn), (2017-2022)
    Table 42. Google DeepMind Corporate Summary
    Table 43. Google DeepMind Artificial Intelligence Drug R&D Product Offerings
    Table 44. Google DeepMind Artificial Intelligence Drug R&D Revenue (US$, Mn), (2017-2022)
    Table 45. Genpact Cora Corporate Summary
    Table 46. Genpact Cora Artificial Intelligence Drug R&D Product Offerings
    Table 47. Genpact Cora Artificial Intelligence Drug R&D Revenue (US$, Mn), (2017-2022)
    Table 48. Cyclica Inc Corporate Summary
    Table 49. Cyclica Inc Artificial Intelligence Drug R&D Product Offerings
    Table 50. Cyclica Inc Artificial Intelligence Drug R&D Revenue (US$, Mn), (2017-2022)
    Table 51. QuantumBlack Corporate Summary
    Table 52. QuantumBlack Artificial Intelligence Drug R&D Product Offerings
    Table 53. QuantumBlack Artificial Intelligence Drug R&D Revenue (US$, Mn), (2017-2022)
    Table 54. Nq Medical Corporate Summary
    Table 55. Nq Medical Artificial Intelligence Drug R&D Product Offerings
    Table 56. Nq Medical Artificial Intelligence Drug R&D Revenue (US$, Mn), (2017-2022)
    Table 57. Phenomic AI Corporate Summary
    Table 58. Phenomic AI Artificial Intelligence Drug R&D Product Offerings
    Table 59. Phenomic AI Artificial Intelligence Drug R&D Revenue (US$, Mn), (2017-2022)
    Table 60. Palantir Technologies Corporate Summary
    Table 61. Palantir Technologies Artificial Intelligence Drug R&D Product Offerings
    Table 62. Palantir Technologies Artificial Intelligence Drug R&D Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Artificial Intelligence Drug R&D Segment by Type in 2021
    Figure 2. Artificial Intelligence Drug R&D Segment by Application in 2021
    Figure 3. Global Artificial Intelligence Drug R&D Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Artificial Intelligence Drug R&D Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Artificial Intelligence Drug R&D Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Artificial Intelligence Drug R&D Revenue in 2021
    Figure 8. By Type - Global Artificial Intelligence Drug R&D Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Artificial Intelligence Drug R&D Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Artificial Intelligence Drug R&D Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Artificial Intelligence Drug R&D Revenue Market Share, 2017-2028
    Figure 12. US Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Artificial Intelligence Drug R&D Revenue Market Share, 2017-2028
    Figure 16. Germany Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2017-2028
    Figure 17. France Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Artificial Intelligence Drug R&D Revenue Market Share, 2017-2028
    Figure 24. China Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2017-2028
    Figure 28. India Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Artificial Intelligence Drug R&D Revenue Market Share, 2017-2028
    Figure 30. Brazil Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Artificial Intelligence Drug R&D Revenue Market Share, 2017-2028
    Figure 33. Turkey Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Artificial Intelligence Drug R&D Revenue, (US$, Mn), 2017-2028
    Figure 37. IBM Watson Artificial Intelligence Drug R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. BioXel Artificial Intelligence Drug R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Insilico Medicine Artificial Intelligence Drug R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Gatehouse Bio Artificial Intelligence Drug R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Google DeepMind Artificial Intelligence Drug R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Genpact Cora Artificial Intelligence Drug R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Cyclica Inc Artificial Intelligence Drug R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. QuantumBlack Artificial Intelligence Drug R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Nq Medical Artificial Intelligence Drug R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Phenomic AI Artificial Intelligence Drug R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. Palantir Technologies Artificial Intelligence Drug R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
62
Frequently Asked Questions
Artificial Intelligence Drug R&D Market In Global report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Artificial Intelligence Drug R&D Market In Global report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Artificial Intelligence Drug R&D Market In Global report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports